RAC1 and pancreatic neoplasm: Our data show that the inhibition of Rac1 abrogates the IR-induced G2 checkpoint activation in the pancreatic cancer cells (see Fig. 3–6) but only has subtle, if any, effect on the IR-induced G1 and G2 checkpoint responses of the normal HPNE cells (see Fig. 3D).